Product Information

CYCLOSPORINE 0.05% EYE EMULSION is a generic product labeled by Devatis Inc., priced at $0.9240 per EA under NDC 73043000502. Its NADAC has been published 76 times since Mar 12, 2025.

FDA first approved this application on May 21, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CYCLOSPORINE 0.05% EYE EMULSION

cyclosporine
$0.9240per EA

Strength

.5 mg/mL

Manufacturer

Devatis Inc.

NDC

73043000502

Classification

Generic

Dosage Form

EMULSION

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

CYCLOSPORINE

Approval Type

Generic (ANDA)

FDA Application

ANDA209811

FDA Approved

5/21/2024

TE Code

AB

On Market Since

7/4/2024

Pharmacological Classes

Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for CYCLOSPORINE 0.05% EYE EMULSION has been published 76 times since Mar 12, 2025, and over the history we have for it it has declined 58.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9240 per EA
All-time high$2.3287 (May 14, 2025)
All-time low$0.9240 (Aug 19, 2026)
52-week high$2.1087
52-week low$0.9240
Median price$1.9090
Average price$1.7930
Largest weekly change-11.2% (Jul 22, 2026)
Weeks tracked76
Tracking sinceMar 12, 2025

Price History

1W

-3.9%

1M

-14.7%

3M

-24.0%

6M

-42.4%

1Y

-56.6%

3Y

N/A

5Y

N/A

All

-58.1%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CYCLOSPORINE 0.05% EYE EMULSION?

The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE 0.05% EYE EMULSION, manufactured by Devatis Inc., is $0.9240 per EA (NDC 73043000502), effective Aug 19, 2026.

How has the price of CYCLOSPORINE 0.05% EYE EMULSION changed over time?

Over the history we have for it, the NADAC for CYCLOSPORINE 0.05% EYE EMULSION has declined 58.1%. It has been tracked across 76 weekly CMS publications since Mar 12, 2025.

What are the highest and lowest recorded NADAC prices for CYCLOSPORINE 0.05% EYE EMULSION?

Since Mar 12, 2025, the NADAC for CYCLOSPORINE 0.05% EYE EMULSION has ranged from a low of $0.9240 (Aug 19, 2026) to a high of $2.3287 (May 14, 2025), with a median of $1.9090 per EA.

Are there cheaper alternatives to CYCLOSPORINE 0.05% EYE EMULSION?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOSPORINE 0.05% EYE EMULSION in a comparable dosage form, but none are currently priced below it.

Who manufactures CYCLOSPORINE 0.05% EYE EMULSION?

CYCLOSPORINE 0.05% EYE EMULSION (NDC 73043000502) is labeled by Devatis Inc., and CMS classifies it as a generic product.